Translational Development Acquisition Corp. (TDACU) Prices $150M IPO
by Kristi Marvin on 2024-12-23 at 10:52am

Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024.

The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that complement the management team’s background.

Translational Development Acquisition Corp.’s sponsor team is led by Chief Executive Officer and Director Michael B. Hoffman, and Chief Financial Officer Avanindra C. Das.

E. Premkumar Reddy, Curtis T. Keith, Matthew A. Kestenbaum, and Christopher Jarratt will serve on its Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 57. This offering is expected to close on Tuesday, December 24, 2024.


BTIG, LLC is acting as sole book-running manager for the offering. Venable LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Transfer & Trust Company is acting as trustee.

Recent Posts
by Kristi Marvin on 2024-12-26 at 1:59pm

SPACInsider 2024 Awards 2024 was clearly a rebuilding year for SPACs and the pace didn’t really gather momentum until June. But in typical SPAC fashion, once the market catches fire, it builds very, very quickly. With that being said, there are some noteworthy standouts this year that are worth highlighting. As such, this is the...

by Nicholas Alan Clayton on 2024-12-26 at 8:07am

At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...

by Nicholas Alan Clayton on 2024-12-24 at 2:07pm

Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...

by Nicholas Alan Clayton on 2024-12-24 at 8:13am

At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...

by Nicholas Alan Clayton on 2024-12-23 at 3:40pm

Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved